N-(2-{[(4-Bromo-1,2-thiazol-3-yl)methyl]sulfanyl}ethyl)-N'-methylthiourea → N-cyano-N'-[2-((4-bromo-3-isothiazolyl)methylthio)ethyl]-N"-methylguanidine

HRID 1974417

反応式

HRID 1974417 の反応式
[CH3:1][NH:2][C:3]([NH:5][CH2:6][CH2:7][S:8][CH2:9][C:10]1[C:14]([Br:15])=[CH:13][S:12][N:11]=1)=S.[N:16]#[C:17][NH2:18].[Pb]>>[C:17]([NH:18][C:3]([NH:5][CH2:6][CH2:7][S:8][CH2:9][C:10]1[C:14]([Br:15])=[CH:13][S:12][N:11]=1)=[N:2][CH3:1])#[N:16]

参加物

3

実験手順

The reaction of 4-bromo-3-(bromomethyl)isothiazole (8.5 g) with cysteamine (from cysteamine hydrochloride, 3.76 g) was performed under conditions similar to those described in Example 91. From the reaction there was obtained 4-bromo-3-[(2-aminoethyl)thiomethyl]isothiazole hydrobromide, which, following recrystallisation from ethanol-ether and acetonitrile, gave needles (4.05 g) m.p. 111°-112°. The amine base (2.73 g) was isolated by basification with sodium hydroxide and extraction with chloroform and then dissolved in ethanol and treated with methyl isothiocyanate (0.78 g). The solution was heated under reflux for 30 minutes, concentrated and the residue triturated with ether to yield the crystalline thiourea (2.9 g) m.p. 60°-61°. Recrystallisation from isopropyl acetate gave N-methyl-N'-[2-((4-bromo-3-isothiazolyl)methylthio)ethyl]thiourea (2.3 g) as needles, m.p. 62°-63°: Reaction of N-methyl-N'-[2-((4-bromo-3-isothiazolyl)-methylthio)ethyl]thiourea with lead cyanamide by the procedure of Example 91 gives N-cyano-N'-[2-((4-bromo-3-isothiazolyl)methylthio)ethyl]-N"-methylguanidine. Hydrolysis of the above product according to the procedure of Example 84 gives N-[2-((4-bromo-3 -isothiazolyl)methylthio) ethyl]-N'-methylguanidine hydrochloride.

出典と根拠

ORDレコード
ord-5c0f27b96b2a4101bd67c2c7ec2fe3c8
出典データセット
uspto-grants-1976_12
特許番号
US04000302

関連ノート

読み込み中…